GlassScriptPhysician profile
Soheil Vahdani
NPI 1497274252
$7,008.10
in general payments reported to CMS, 2019-2025
8 companies · $1,335 in 2025
The $1,335 reported for 2025 was more than what 88% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $237 · 2022: $894 · 2023: $2,619 · 2024: $1,923 · 2025: $1,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,799 · Travel and Lodging: $2,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,799.20 |
| Travel and Lodging | $2,078.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,629.05 | 2021-2025 | Na, Vsp System, Vsp Cranial, Colorado |
| Axogen | $1,863.75 | 2023 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Zimvie INC. | $1,332.00 | 2022-2025 | |
| Kls-Martin L.P. | $686.59 | 2021-2025 | |
| Straumann USA LLC | $308.81 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $123.38 | 2023-2024 | Traumaone |
| Depuy Synthes Sales INC. | $44.71 | 2024 | Na |
| Alon Medical Technology | $19.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soheil Vahdani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.